← Back to Search

Ankle Mobilization for Knee Pain

N/A
Recruiting
Led By Everett Lohman, Dsc
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and post intervention on day 1
Awards & highlights

Study Summary

This trial is testing if limited ankle movement affects knee pain when doing a one-legged squat.

Who is the study for?
This trial is for women aged 18-59 with Patellofemoral Pain lasting at least 6 months, who haven't had clinic treatments in that time. They must have limited ankle movement (<45 degrees on a lunge test) and no knee swelling, abnormal limb structures, severe resting pain, or past surgery/fractures affecting leg/spine biomechanics.Check my eligibility
What is being tested?
The study examines how limited ankle flexibility affects single-leg squats in those with knee pain. Participants will either receive 'Mobilization with Movement' therapy or just education without mobilization to see which method better improves squat performance.See study design
What are the potential side effects?
Since the interventions involve physical therapy techniques and educational components rather than medication, side effects are minimal but may include temporary discomfort or muscle soreness from the movements performed during the sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and post intervention on day 1
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline and post intervention on day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Weight bearing lunge test
Secondary outcome measures
Patellofemoral Disability Index

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Primary Intervention GroupExperimental Treatment1 Intervention
The experimental group will receive two interventions to increase dorsiflexion range of motion.
Group II: Minimal Intervention GroupActive Control1 Intervention
The minimal intervention group will read and infographic and complete 5 minutes of treadmill walking.

Find a Location

Who is running the clinical trial?

Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,924 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
43 Patients Enrolled for Patellofemoral Pain Syndrome
Everett Lohman, DscPrincipal InvestigatorLoma Linda University
2 Previous Clinical Trials
79 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
43 Patients Enrolled for Patellofemoral Pain Syndrome

Media Library

Mobilization with Movement Clinical Trial Eligibility Overview. Trial Name: NCT05285007 — N/A
Patellofemoral Pain Syndrome Research Study Groups: Minimal Intervention Group, Primary Intervention Group
Patellofemoral Pain Syndrome Clinical Trial 2023: Mobilization with Movement Highlights & Side Effects. Trial Name: NCT05285007 — N/A
Mobilization with Movement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05285007 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to join this medical experiment?

"This clinical trial is seeking 60 individuals between 18 and 59 years old who are suffering from patellofemoral pain."

Answered by AI

How many participants are being recruited for this trial?

"Affirmative. The clinicaltrials.gov's records indicate that this research study is actively enrolling participants, with 60 individuals needed across one location. This trial was first established on March 2nd 2022 and most recently revised on the 15th of March in the same year."

Answered by AI

Are there new participant openings for this experiment?

"According to the information posted on clinicaltrials.gov, this medical study is actively enrolling patients in need of treatment. The trial was launched on March 2nd 2022 and underwent its last revision two weeks later, on March 15th 2022."

Answered by AI

Is eligibility for the trial contingent upon age, and if so, what is the cutoff?

"This clinical trial has set an age range of 18 to 59 for inclusion, while 4 other studies are targeting minors and 6 others focus on elderly patients."

Answered by AI
~15 spots leftby Jan 2025